← Eichor
Study identifier: NCT06904456 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia

Condition: Advanced HIV Disease  ·  Sponsor: Boston University

PhaseN/A
Planned participants11800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In Zambia, an estimated 20% of HIV-positive clients continue to present for first-time antiretroviral therapy (ART) initiation or re-initiation with advanced HIV disease (AHD). The Zambia Ministry of Health (MOH) and other key stakeholders lack information about the characteristics and behaviors of AHD clients, including how they are defined and diagnosed (e.g. low CD4 count v. clinical condition), their demographic and socioeconomic profiles, their HIV care histories, what services they receive, and their short-term outcomes (achieve viral suppression, remain AHD, disengage from care, die) and the timing of these outcomes. The Retain6 project aims to improve HIV treatment outcomes during clients' first six months on ART, when disengagement from care and mortality are highest. This protocol, called Advanced HIV disease during the first six months on antiretroviral therapy in Zambia (AHD Zambia), describes an observational study that will describe the experiences of clients who are diagnosed with AHD upon ART initiation (or re-initiation) in Zambia. Data collected will include clinical and socioeconomic characteristics, clinical and non-clinical needs, services delivered and received, and clients' and providers' concerns and preferences. The study's overall goal is to provide information to the Zambia MOH, treatment program partners, providers, and other stakeholders to better understand who is presenting with AHD in Zambia, how they are currently managed, and their treatment…

This description comes directly from the study's public registry record.

Talk to the study team

Sydney Rosen, MPA  ·  (857) 207-7909  ·  sbrosen@bu.edu

Nancy Scott, DrPH MPH  ·  (720) 345-4386  ·  nscott@bu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

CHAI-ZambiaLusaka, ZambiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06904456